NCT02978677View on ClinicalTrials.gov

Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas

NANot yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Meningioma
Interventions
RADIATION

Radiotherapy 68 Gy(RBE)

Radiotherapy 2.0 to 50 Gy(RBE) photon or proton and boost 2 to 18 Gy(RBE) proton

RADIATION

Radiotherapy 72 Gy(RBE)

Radiotherapy 2.0 to 50 Gy(RBE) photon or proton and boost 2 to 18 Gy(RBE) proton and boost 2 to 4 Gy(RBE) proton

RADIATION

Radiotherapy 60 Gy(RBE)

Radiotherapy 2.0 to 50 Gy(RBE) photon or proton and boost 2 to 10 Gy(RBE) proton

All Listed Sponsors
collaborator

German Cancer Research Center

OTHER

collaborator

Radiation Oncology Working Group of the German Cancer Society

OTHER

lead

Technische Universität Dresden

OTHER

NCT02978677 - Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas | Biotech Hunter | Biotech Hunter